Navigation Links
Molecular coordination in evolution: A review in 'Nature Reviews Genetics'
Date:3/5/2013

Spanish National Cancer Research Centre (CNIO) researchers Alfonso Valencia, Director of the Structural Biology and Biocomputing Programme and David de Juan, jointly with Florencio Pazos, from the Spanish National Centre for Biotechnology (CNB-CSIC), publish a review on the latest computational methods that, based on evolutionary principles, are revolutionising the field of analysis and prediction of protein structure, function and protein-protein interactions, as well as the short- and long-term expectations for the field.

"The computational and mathematical analysis tools that study how proteins evolve in a coordinated fashion a process known as molecular coevolution have undergone important changes over the past few years", explains Valencia.

This revolution in the study of microscale evolution is allowing researchers to predict interactions between proteins and to understand the structural changes that take place in these molecules. It also represents the basis for understanding how mutations caused by diseases such as cancer or neurodegenerative disease affect their underlying molecular framework.

Proteins just like the different species at the macroscopic level, via competitive or symbiotic interactions do not act in an isolated manner but rather coordinate amongst themselves in order to carry out their functional roles. These biological relationships explain why there is a tendency in evolution to introduce coordinated changes in proteins, which allow for the preservation and modulation of these relationships.

"The development of new, more powerful and more reliable mathematical methods than those available in the 1990s is allowing us to explore these biological problems at the molecular level, and provide a deeper vision of the Darwinian process," says Valencia. "These methods based on coevolution are like a telescope, helping us to observe and understand biological and molecular processes."

MORE THAN 20 YEARS OF RESEARCH PREDICTING MOLECULAR RELATIONSHIPS

In the revision, the authors describe those mathematical methods that, based on the evolution of pairs of proteins, are capable of predicting molecular interactions at different levels of complexity.

These methods include those approaches from the 1990s that predicted contact points between proteins; those that allow us to understand binding selectivity between very similar proteins -or ones that belong to the same family- and their ligands; or even, at a deeper level of complexity, those that predict interaction networks between the thousands of proteins that make up cells.

Over the last 20 years, Valencia's team has led several lines of research related to this field, many of which are still being studied by many other groups and in which his team continues to be a world leader.

"In 2012, we published a new set of predictions on the specificity of the binding of the Ras oncogene to other proteins. The tool was based on coevolution methods that we had developed a couple of years ago, and that are now being widely explored by other groups," explains Valencia. The Ras protein family is associated with a wide spectrum of cancers, so learning the language it uses with other proteins that are important for cells might open avenues for the development of novel drugs.

The authors of the study foresee a promising future for this field, in which bioinformatics programmers, physicists, biologists and mathematicians join forces in order to describe the complexity of protein dynamics.

"In the long term, we hope that unifying these methods will help us to manipulate or create new drugs that selectively target abnormal cells and therefore reduce side effects," says de Juan.


'/>"/>
Contact: Nuria Noriega
nnoriega@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)
Source:Eurekalert

Related medicine news :

1. Obesity, physical inactivity linked with risk for certain molecular subtype of colorectal cancer
2. UNC-led study documents head and neck cancer molecular tumor subtypes
3. Molecular master switch for pancreatic cancer identified, potential predictor of treatment outcome
4. New details on the molecular machinery of cancer
5. U of M researchers develop a molecular calcium sponge to tackle heart failure
6. Researchers use new molecular inhibitors to successfully hit difficult cancer target
7. PLEXERA® LLC Launches Contract Research Services Business for Biomolecular Interaction Studies
8. Research suggests molecular switch may play role in tumor suppression
9. Trying to halt hepatitis Cs molecular hijacking
10. Springer launches new journal with the Italian Association of Nuclear Medicine and Molecular Imaging
11. Metabolic biomarkers for preventive molecular medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... ... specializing in medical device compliance and commercialization, has just released a new ... , FDA is more adamant than ever about medical device, pharmaceutical, and ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part of The Garland ... a redesigned website. The new site – still located at http://www.garlandco.com ... and other industry users that Garland serves. , After an ambitious phase of ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... digital and social campaign, “Humans With Vaginas.” The goal is to ignite conversation ... of non-toxic personal care products. The brand has declared September “Humans with Vaginas” ...
(Date:9/20/2017)... ... 20, 2017 , ... Health & Safety Institute (HSI) is offering discounted pricing ... 40-Hour courses from now until November 30, 2017 to assist with the clean-up efforts ... to all businesses and government agencies – whether or not they will be directly ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the exciting story of ... life. This mouse sets out on a journey that will show that friends are ... creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a bachelor’s ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
Breaking Medicine Technology: